Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FENDEEP Study
2021-002821-32Phase 4Active
- Sponsor
- Neurología Aplicada
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fenfluramine in epileptic encephalopathy and epilepsy, sponsored by Neurología Aplicada. Primary endpoint: Reduction in seizure frequency. Started Dec 2021; status: active.
02
Drugs
fenfluramine
03
Conditions
epileptic encephalopathyepilepsy
Beyond the preview
Go deeper on 2021-002821-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002821-32.